Product information and disease descriptionProduct descriptionProduct information
Generic, brand name and therapeutic class of product
4 evidence topics · 7 sources
Generic name, chemical name, and identifiers
| Field | Quoted record |
|---|---|
| International nonproprietary name (Latin) | “obefazimodum” |
| International nonproprietary name (English) | “obefazimod” |
| Chemical name | “8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine” |
| Functional description | “immunomodulator” |
| Molecular formula | “C16H10ClF3N2O” |
| CAS registry number | “1258453-75-6” |
| INN list | “Proposed INN: List 125” |
Development code: ABX464
Brand name
No evidence found.
Therapeutic class: oral small molecule miR-124 enhancer
“Obefazimod is an oral small molecule that selectively enhances the expression of a single micro-RNA (miRNA), miR-124.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Obefazimod (ABX464) is a first-in-class, oral small molecule that enhances microRNA-124 (miR-124) biogenesis, suppressing STAT3 and CCL2 signaling, reducing Th17 polarization and macrophage activation.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote